Abstract
Purpose
To report a case of endophthalmitis associated with Purpureocillium lilacinum (P. lilacinum) during infliximab treatment for surgically induced necrotizing scleritis, successfully treated with 27-gauge vitrectomy.
Methods
A single case report.
Results
A 71-year-old man who had undergone immunosuppressive therapy, including infliximab, for surgically induced necrotizing scleritis (SINS) in his left eye complained of visual disturbance and eye pain in the eye. He had a past history of surgery for recurrent pterygium: pterygium excision, amnion transplantation with mitomycin C and limbal transplantation. Visual acuity in the left eye was counting fingers at 30 cm, and intraocular pressure was 3.0 mmHg. Slit-lamp examination revealed the presence of anterior chamber cells (3+), and a B-mode ultrasound scan showed a vitreous opacity. We made a diagnosis of endophthalmitis and performed 27-gauge microincision vitrectomy surgery (27GMIVS) with antibiotic perfusion of ceftazidime, vancomycin and voriconazole. Intraoperative findings included a fungus-like ball-shaped opacity in the vitreous, and a close-to-normal retinal appearance. A vitreous body culture identified the presence of P. lilacinum. After 2 months of antibacterial and antifungal therapy, inflammation decreased and visual acuity recovered to 20/100.
Conclusions
This is the first report of a case of endophthalmitis associated with P. lilacinum during infliximab treatment for SINS. Scleral thinning due to necrotizing scleritis, especially during immunosuppressive therapy, is a risk factor for endophthalmitis. We found that 27GMIVS was a useful strategy for such a challenging clinical situation.
References
Klotz SA, Penn CC, Negvesky GJ, Butrus SI (2000) Fungal and parasitic infections of the eye. Clin Microbiol Rev 13:662–685. doi:10.1128/CMR.13.4.662-685.2000
Thomas PA (2003) Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 16:730–797. doi:10.1128/CMR.16.4.730
Walsh TJ, Groll A, Hiemenz J et al (2004) Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10:48–66. doi:10.1111/j.1470-9465.2004.00839.x
Rychly DJ, Pharm D, Dipiro JT, Pharm D (2005) Infections associated with tumor necrosis factor-α antagonists. Pharmacotherapy 25:1181–1192
Crum NF, Lederman ER, Wallace MR (2005) Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore) 84:291–302. doi:10.1097/01.md.0000180044.19285.9a
Luangsa-Ard J, Houbraken J, van Doorn T et al (2011) Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett 321:141–149. doi:10.1111/j.1574-6968.2011.02322.x
Pastor FJ, Guarro J (2006) Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 12:948–960. doi:10.1111/j.1469-0691.2006.01481.x
Oshima Y, Wakabayashi T, Sato T et al (2010) A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology 117(93–102):e2. doi:10.1016/j.ophtha.2009.06.043
Kunimoto DY, Kaiser RS, Wills Eye Retina Service (2007) Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology 114:2133–2137. doi:10.1016/j.ophtha.2007.08.009
Oshima Y, Kadonosono K, Yamaji H et al (2010) Multicenter survey with a systematic overview of acute-onset endophthalmitis after transconjunctival microincision vitrectomy surgery. Am J Ophthalmol 150(716–725):e1. doi:10.1016/j.ajo.2010.06.002
Fassbender JM, Jusufbegovic D, Schaal S (2016) Postcataract endophthalmitis treated with small gauge vitrectomy. Retin Cases Brief Rep 10:320–322. doi:10.1097/ICB.0000000000000346
Khan MA, Shahlaee A, Toussaint B et al (2016) Outcomes of 27 gauge microincision vitrectomy surgery for posterior segment disease. Am J Ophthalmol 161:36–43. doi:10.1016/j.ajo.2015.09.024
White TJ, Bruns T, Lee STJ et al (1990) Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols: a guide to methods and applications. Academic Press, San Diego, pp 315–322
Markomichelakis N, Delicha E, Masselos S et al (2011) A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet’s disease: a comparative 4-week study. Rheumatology 50:593–597. doi:10.1093/rheumatology/keq366
Okada AA, Goto H, Ohno S et al (2012) Multicenter study of infliximab for refractory uveoretinitis in Behcet disease. Arch Ophthalmol 130:592–598. doi:10.1001/archophthalmol.2011.2698
Richards JC, Tay-Kearney ML, Murray K, Manners P (2005) Infliximab for juvenile idiopathic arthritis-associated uveitis. Clin Exp Ophthalmol 33:461–468. doi:10.1111/j.1442-9071.2005.01062.x
Levy-Clarke G, Jabs DA, Read RW et al (2014) Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology 121:785–796. doi:10.1016/j.ophtha.2013.09.048
Turner LD, Conrad D (2015) Retrospective case-series of Paecilomyces lilacinus ocular mycoses in Queensland, Australia. BMC Res Notes 8:627. doi:10.1186/s13104-015-1591-0
Todokoro D, Yamada N, Fukuchi M, Kishi S (2014) Topical voriconazole therapy of Purpureocillium lilacinum keratitis that occurred in disposable soft contact lens wearers. Int Ophthalmol 34:1159–1163. doi:10.1007/s10792-014-9965-1
Endophthalmitis Vitrectomy Study Group (1995) Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol (Chic, Ill 1960) 113:1479–1496
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The case presentation conforms to the principles of the Declaration of Helsinki.
Rights and permissions
About this article
Cite this article
Yoshida, M., Yokokura, S., Kunikata, H. et al. Endophthalmitis associated with Purpureocillium lilacinum during infliximab treatment for surgically induced necrotizing scleritis, successfully treated with 27-gauge vitrectomy. Int Ophthalmol 38, 841–847 (2018). https://doi.org/10.1007/s10792-017-0532-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-017-0532-4